InnovAge Holding Corp. Basic Shares Outstanding (Weighted Average)
InnovAge Holding Corp. (INNV) reported Basic Shares Outstanding (Weighted Average) of 135.70 million shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-09-09
- InnovAge Holding Corp. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 135.81M shares, a 0.50% increase year-over-year.
- InnovAge Holding Corp. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 135.70M shares, a 0.37% increase year-over-year.
- InnovAge Holding Corp. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 135.69M shares, a 0.18% increase year-over-year.
- InnovAge Holding Corp. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 135.59M shares, a 0.13% decline year-over-year.
- InnovAge Holding Corp. weighted average number of shares outstanding, basic for fiscal 2026 was 135.70M shares, a 0.23% increase from fiscal 2025.
- InnovAge Holding Corp. weighted average number of shares outstanding, basic for fiscal 2025 was 135.39M shares, a 0.38% decline from fiscal 2024.
- InnovAge Holding Corp. weighted average number of shares outstanding, basic for fiscal 2024 was 135.90M shares, a 0.23% increase from fiscal 2023.
- InnovAge Holding Corp. weighted average number of shares outstanding, basic for fiscal 2023 was 135.59M shares, a 0.05% increase from fiscal 2022.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 135.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | 135.76M shares derived: average of 2 quarters · filed 2026-09-09 | 135.73M shares derived: average of 3 quarters · filed 2026-09-09 | 135.70M shares 10-K · filed 2026-09-09 |
| 2026-03-31 | 135.70M shares 10-Q · filed 2026-05-08 | 135.70M shares derived: average of 2 quarters · filed 2026-05-08 | 135.66M shares 10-Q · filed 2026-05-08 | 135.53M shares derived: average of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | 135.69M shares 10-Q · filed 2026-02-03 | 135.64M shares 10-Q · filed 2026-02-03 | 135.47M shares derived: average of 3 quarters · filed 2026-09-09 | 135.40M shares derived: average of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | 135.59M shares 10-Q · filed 2025-11-04 | 135.36M shares derived: average of 2 quarters · filed 2026-09-09 | 135.31M shares derived: average of 3 quarters · filed 2026-09-09 | 135.34M shares derived: average of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | 135.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | 135.17M shares derived: average of 2 quarters · filed 2026-09-09 | 135.26M shares derived: average of 3 quarters · filed 2026-09-09 | 135.39M shares 10-K · filed 2026-09-09 |
| 2025-03-31 | 135.20M shares 10-Q · filed 2026-05-08 | 135.32M shares derived: average of 2 quarters · filed 2026-05-08 | 135.47M shares 10-Q · filed 2026-05-08 | 135.61M shares derived: average of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | 135.44M shares 10-Q · filed 2026-02-03 | 135.60M shares 10-Q · filed 2026-02-03 | 135.74M shares derived: average of 3 quarters · filed 2026-02-03 | 135.79M shares derived: average of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | 135.77M shares 10-Q · filed 2025-11-04 | 135.90M shares derived: average of 2 quarters · filed 2025-11-04 | 135.90M shares derived: average of 3 quarters · filed 2025-11-04 | 135.90M shares derived: average of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | 136.02M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | 135.97M shares derived: average of 2 quarters · filed 2025-09-09 | 135.94M shares derived: average of 3 quarters · filed 2025-09-09 | 135.90M shares 10-K · filed 2025-09-09 |
| 2024-03-31 | 135.91M shares 10-Q · filed 2025-05-06 | 135.90M shares derived: average of 2 quarters · filed 2025-05-06 | 135.86M shares 10-Q · filed 2025-05-06 | 135.80M shares derived: average of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | 135.89M shares 10-Q · filed 2025-02-04 | 135.84M shares 10-Q · filed 2025-02-04 | 135.77M shares derived: average of 3 quarters · filed 2025-02-04 | 135.73M shares derived: average of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | 135.79M shares 10-Q · filed 2024-11-05 | 135.71M shares derived: average of 2 quarters · filed 2024-11-05 | 135.67M shares derived: average of 3 quarters · filed 2024-11-05 | 135.65M shares derived: average of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | 135.63M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | 135.62M shares derived: average of 2 quarters · filed 2024-09-10 | 135.60M shares derived: average of 3 quarters · filed 2024-09-10 | 135.59M shares 10-K · filed 2024-09-10 |
| 2023-03-31 | 135.60M shares 10-Q · filed 2024-05-07 | 135.59M shares derived: average of 2 quarters · filed 2024-05-07 | 135.58M shares 10-Q · filed 2024-05-07 | 135.57M shares derived: average of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | 135.58M shares 10-Q · filed 2024-02-06 | 135.57M shares 10-Q · filed 2024-02-06 | 135.56M shares derived: average of 3 quarters · filed 2024-02-06 | 135.55M shares derived: average of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | 135.57M shares 10-Q · filed 2023-11-07 | 135.55M shares derived: average of 2 quarters · filed 2023-11-07 | 135.54M shares derived: average of 3 quarters · filed 2023-11-07 | 135.53M shares derived: average of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | 135.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12 | 135.52M shares derived: average of 2 quarters · filed 2023-09-12 | 135.52M shares derived: average of 3 quarters · filed 2023-09-12 | 135.52M shares 10-K · filed 2023-09-12 |
| 2022-03-31 | 135.52M shares 10-Q · filed 2023-05-09 | 135.52M shares derived: average of 2 quarters · filed 2023-05-09 | 135.52M shares 10-Q · filed 2023-05-09 | 135.54M shares derived: average of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | 135.52M shares 10-Q · filed 2023-02-07 | 135.52M shares 10-Q · filed 2023-02-07 | 135.55M shares derived: average of 3 quarters · filed 2023-02-07 | 131.99M shares derived: average of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | 135.52M shares 10-Q · filed 2022-11-08 | 135.57M shares derived: average of 2 quarters · filed 2022-11-08 | 130.82M shares derived: average of 3 quarters · filed 2022-11-08 | 127.24M shares derived: average of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | 135.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | 128.47M shares derived: average of 2 quarters · filed 2022-09-13 | 124.49M shares derived: average of 3 quarters · filed 2022-09-13 | 123.62M shares 10-K · filed 2022-09-13 |
| 2021-03-31 | 121.32M shares 10-Q · filed 2022-05-10 | 118.92M shares derived: average of 2 quarters · filed 2022-05-10 | 119.62M shares 10-Q · filed 2022-05-10 | 122.90M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | 116.52M shares 10-Q · filed 2022-02-09 | 118.80M shares 10-Q · filed 2022-02-09 | 123.42M shares derived: average of 3 quarters · filed 2022-02-09 | 125.72M shares derived: average of 4 quarters · filed 2022-02-09 |
| 2020-09-30 | 121.12M shares 10-Q · filed 2021-11-09 | 126.87M shares derived: average of 2 quarters · filed 2021-11-09 | 128.78M shares derived: average of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | 132.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | 132.62M shares derived: average of 2 quarters · filed 2021-09-23 | 132.62M shares 10-K · filed 2021-09-23 | |
| 2020-03-31 | 132.62M shares 10-Q · filed 2021-05-11 | 132.62M shares 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |